Scarica l'app Stockscreener
0.4735
4.15%
-0.0205
Dopo l'orario di chiusura:
.50
0.0265
+5.60%
Precedente Chiudi:
$0.494
Aprire:
$0.47
Volume 24 ore:
481.10K
Relative Volume:
1.02
Capitalizzazione di mercato:
$20.92M
Reddito:
$86.55M
Utile/perdita netta:
$-56.70M
Rapporto P/E:
-0.3686
EPS:
-1.2845
Flusso di cassa netto:
$4.87M
1 W Prestazione:
-13.91%
1M Prestazione:
-14.62%
6M Prestazione:
+7.22%
1 anno Prestazione:
-26.03%
Intervallo 1D:
$0.459
$0.4906
Intervallo di 1 settimana:
$0.40
$0.5422
Portata 52W:
$0.2813
$0.9458
Harvard Bioscience Inc Stock (HBIO) Company Profile
Nome
Harvard Bioscience Inc
Settore
Industria
Telefono
(508) 893-8999
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.4735 | 20.92M | 86.55M | -56.70M | 4.87M | -1.2845 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Iniziato | Northland Capital | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Downgrade | Janney | Buy → Neutral |
| 2018-01-24 | Reiterato | Janney | Buy |
| 2018-01-23 | Reiterato | The Benchmark Company | Buy |
| 2016-11-17 | Iniziato | Singular Research | Buy |
| 2015-07-28 | Iniziato | The Benchmark Company | Buy |
Mostra tutto
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com Nigeria
HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com
Harvard Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-03-13 - Seeking Alpha
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: - GuruFocus
Earnings Call Summary | Harvard Bioscience(HBIO.US) Q4 2025 Earnings Conference - 富途牛牛
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harvard Bioscience: Q4 Earnings Snapshot - Chron
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria
Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada
Harvard Bioscience Q4 & Annual Financial Results 2025News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com
HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus
Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus
HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus
Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget
Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView
HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative
Harvard Bioscience Q4 revenue falls 3%, reports net loss - TradingView
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
Harvard Bioscience promotes Frost to CFO - Worcester Business Journal
Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions - Minichart
Harvard Bioscience Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Harvard Bioscience Updates Executive Contracts and Finance Leadership - TipRanks
Harvard Bioscience, Inc. Appoints Mark Frost as Chief Financial Officer, Effective March 6, 2026 - marketscreener.com
Harvard Bioscience Announces Reverse Stock Split - 富途牛牛
Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight - Nasdaq
Aug Volume: Can Harvard Bioscience Inc grow without external funding2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Bank Watch: Can Harvard Bioscience Inc navigate macro headwindsTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Harvard Bioscience executes 1-for-10 reverse stock split - Investing.com
Bull Bear: Does Harvard Bioscience Inc offer margin of safetyJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - baoquankhu1.vn
Harvard Bioscience Approves Reverse Stock Split to Regain Compliance - TipRanks
Harvard Bioscience Announces 1-for-10 Reverse Stock Split Effective March 13, 2026 - Quiver Quantitative
Harvard Bioscience announces reverse stock split - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
[8-K] HARVARD BIOSCIENCE INC Reports Material Event | HBIO SEC FilingForm 8-K - Stock Titan
Harvard Bioscience (HBIO) to Release Quarterly Earnings on Thursday - Defense World
Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - The Manila Times
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - ChartMill
Aug Breakouts: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Earnings & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is Harvard Bioscience Inc. a cyclical or defensive stockBond Market & Fast Gain Stock Tips - mfd.ru
Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What makes Harvard Bioscience Inc. stock attractive to growth fundsJuly 2025 Setups & Verified Trade Idea Suggestions - mfd.ru
Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):